Apligraf
Ended Awarded
- Contract number
- SPE2D626F5915
- Awardee
-
Organogenesis Inc. UEI VKK3WXM4RCZ7
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,240
Award facts
- Contract value 100% obligated
- $1,239.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources · 65 offers Multiple Award, Fair Opportunity
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Canton, MA 02021, USA
Award details come from SAM.gov/FPDS.
About this award
Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $1,239.95 by the Defense Logistics Agency's Medical Supply Chain division on October 28, 2025, with an ultimate completion date of October 31, 2025. The award covers APLIGRAF, an advanced skin substitute product used for wound care and tissue regeneration. This delivery order was issued under a fixed-price contract with economic price adjustment terms and did not utilize a set-aside designation, indicating the company competed as a standard commercial vendor. The place of performance is located in Canton, Massachusetts, where Organogenesis manufactures its regenerative medicine products.
This delivery order falls under one of Organogenesis's larger indefinite delivery vehicles with the Defense Logistics Agency, specifically a $49.5 million multiple-award Indefinite Delivery Contract for medical supplies running through June 2026. The award reflects the company's established role as a key supplier of advanced wound care and surgical biologics to military and defense healthcare systems. Organogenesis has consistently provided specialized medical products to government agencies, including the Department of Veterans Affairs and the Defense Logistics Agency, supporting critical medical treatments for military personnel and veterans through its comprehensive portfolio of regenerative medicine solutions.
Quick answers
Who was awarded contract SPE2D626F5915?
SPE2D626F5915 was awarded to Organogenesis Inc. by Medical Supply Chain (Troop Support) on October 28, 2025.
How much is contract SPE2D626F5915 worth?
The government has obligated $1,240 on SPE2D626F5915.
Is contract SPE2D626F5915 an order under another contract?
Yes. SPE2D626F5915 is a delivery order under SPE2DE21D0005, an indefinite delivery contract.
Was contract SPE2D626F5915 competed?
The extent of competition for SPE2D626F5915 was full and open competition after exclusion of sources. The government received 65 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award